91 related articles for article (PubMed ID: 4945)
1. [Pharmacological action of triazolam].
Furukawa T; Yamasaki M; Hiraga Y; Fukasawa E; Soejima S
Igaku Kenkyu; 1975 Nov; 45(5):285-302. PubMed ID: 4945
[No Abstract] [Full Text] [Related]
2. General pharmacological properties of the new vasodilator flosequinan.
Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S
Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141
[TBL] [Abstract][Full Text] [Related]
3. General pharmacological properties of the main metabolite of flosequinan.
Fujita S; Ikezono K; Umezato M; Hosoki E; Toba Y; Ishikawa M; Kusunoki A; Shintani S
Arzneimittelforschung; 1992 Oct; 42(10):1212-22. PubMed ID: 1335257
[TBL] [Abstract][Full Text] [Related]
4. General pharmacology of amitriptylinoxide.
Leuschner F; Neumann W; Doppelfeld IS; Erdös A; Fontaine R; Gabbar HA; Graf E
Arzneimittelforschung; 1978; 28(10b):1883-93. PubMed ID: 38803
[No Abstract] [Full Text] [Related]
5. Pharmacological activities and side effects of plafibride.
Gras J; Basi N; Zapatero J; Bermejo P; Gimenez F; Beascoa E; Llenas J; Bargalló MA; Giráldez A; Bruseghini L
Arzneimittelforschung; 1981; 31(10a):1808-16. PubMed ID: 6976173
[TBL] [Abstract][Full Text] [Related]
6. [Actions of alpha-sympathomimetics on nervous structures].
Schmitt H
Actual Pharmacol (Paris); 1971; 24():93-131. PubMed ID: 4402554
[No Abstract] [Full Text] [Related]
7. Pharmacological and toxicological studies of binodaline hydrochloride.
Jahn U; Adrian RW; Ismail S; Michos N
Arzneimittelforschung; 1983; 33(5):726-39. PubMed ID: 6683551
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacological properties and chemical structure of tetrahydro-gamma-carbolines].
Shadurskiĭ KS; Il'iuchenok TIu
Farmakol Toksikol; 1969; 32(4):482-5. PubMed ID: 4391083
[No Abstract] [Full Text] [Related]
9. Amphetamine tolerance: central and peripheral studies.
Gerald MC
Psychopharmacol Bull; 1975 Jul; 11(3):59-60. PubMed ID: 1153671
[No Abstract] [Full Text] [Related]
10. 1,4-Benzodiazepines. VIII - Central depressive activity and spasmolytic action of isoquino-[2,1-d] [1,4] benzodiazepines. Structure-activity relationships.
Nikolova M; Ivanov Ch; Ivanova N; Vankov S; Nikolov R
Farmaco Sci; 1982 Aug; 37(8):555-65. PubMed ID: 6127233
[TBL] [Abstract][Full Text] [Related]
11. Action of the benzodiazepines on the cholinergic system.
Consolo S; Garattini S; Ladinsky H
Adv Biochem Psychopharmacol; 1975; (14):63-80. PubMed ID: 242203
[No Abstract] [Full Text] [Related]
12. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacological studies of prazepam].
Furukawa T; Hara T; Kushiku K; Ichimasa S; Yoshihara K
Igaku Kenkyu; 1975 Jul; 45(3):182-203. PubMed ID: 1239906
[No Abstract] [Full Text] [Related]
14. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties.
Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A
Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834
[TBL] [Abstract][Full Text] [Related]
15. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacological effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, a new, antihypertensive substance].
Hoefke W; Kobinger W
Arzneimittelforschung; 1966 Aug; 16(8):1038-50. PubMed ID: 6014885
[No Abstract] [Full Text] [Related]
17. Pharmacological studies on CS-430, a new psychotropic agent.
Kamioka T; Nakayama I; Hara T; Takagi H
Arzneimittelforschung; 1978; 28(5):838-47. PubMed ID: 35173
[TBL] [Abstract][Full Text] [Related]
18. [Antimuscarinic action of parkinsonism drugs on peripheral structures and correlation with central efficacy or clinical dosage].
Oelszner W; Walther H; Wagner U
Acta Biol Med Ger; 1971; 26(5):1045-59. PubMed ID: 5145608
[No Abstract] [Full Text] [Related]
19. [Changes in the sensitivity of the central nervous system to fenazepam at different stages of the recovery period after systemic circulatory arrest in rats].
Mutuskina EA; Garibova TL; Gurvich AM; Voronina TA
Patol Fiziol Eksp Ter; 1990; (4):25-7. PubMed ID: 1981930
[TBL] [Abstract][Full Text] [Related]
20. General pharmacology of the anxiolytic compound metaclazepam in comparison to other benzodiazepines.
Buschmann G; Kühl UG; Rohte O
Arzneimittelforschung; 1985; 35(11):1643-55. PubMed ID: 2868732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
